LivaNova (NASDAQ:LIVN) Hits New 12-Month Low – Here’s What Happened

LivaNova PLC (NASDAQ:LIVN) reached a new 52-week low during trading on Friday . The stock traded as low as $35.44 and last traded at $36.48, with a volume of 823 shares changing hands. The stock had previously closed at $37.48.

Wall Street Analyst Weigh In

A number of analysts have commented on the stock. Barclays decreased their price target on shares of LivaNova from $58.00 to $56.00 and set an “equal weight” rating for the company in a research note on Friday, March 7th. The Goldman Sachs Group lowered their price objective on shares of LivaNova from $64.00 to $55.00 and set a “buy” rating on the stock in a research report on Monday, March 3rd. StockNews.com upgraded LivaNova from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, March 25th. Mizuho cut their target price on LivaNova from $70.00 to $60.00 and set an “outperform” rating for the company in a research note on Wednesday, February 26th. Finally, Needham & Company LLC reaffirmed a “buy” rating and issued a $64.00 price target on shares of LivaNova in a report on Monday, March 17th. Two investment analysts have rated the stock with a hold rating, five have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Buy” and a consensus target price of $61.17.

LivaNova Stock Down 4.1 %

The stock’s 50 day moving average price is $43.47 and its 200-day moving average price is $48.10. The company has a debt-to-equity ratio of 0.46, a quick ratio of 2.87 and a current ratio of 3.37. The company has a market cap of $1.95 billion, a PE ratio of 85.60 and a beta of 0.90.

Institutional Investors Weigh In On LivaNova

Several institutional investors have recently bought and sold shares of the stock. Vanguard Group Inc. increased its holdings in LivaNova by 12.7% during the 4th quarter. Vanguard Group Inc. now owns 2,349,887 shares of the company’s stock valued at $108,823,000 after purchasing an additional 265,291 shares during the period. Capital Research Global Investors boosted its stake in LivaNova by 19.1% in the 4th quarter. Capital Research Global Investors now owns 1,612,818 shares of the company’s stock worth $74,690,000 after purchasing an additional 258,730 shares in the last quarter. Geode Capital Management LLC lifted its stake in shares of LivaNova by 0.6% in the third quarter. Geode Capital Management LLC now owns 1,344,949 shares of the company’s stock worth $70,676,000 after buying an additional 8,331 shares in the last quarter. Dimensional Fund Advisors LP increased its holdings in shares of LivaNova by 8.9% in the 4th quarter. Dimensional Fund Advisors LP now owns 1,310,990 shares of the company’s stock worth $60,710,000 after purchasing an additional 107,693 shares in the last quarter. Finally, Redmile Group LLC lifted its stake in LivaNova by 19.3% during the 4th quarter. Redmile Group LLC now owns 1,043,539 shares of the company’s stock valued at $48,326,000 after acquiring an additional 168,500 shares during the period. 97.64% of the stock is currently owned by hedge funds and other institutional investors.

About LivaNova

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.